- Home
- ALMS vs NPFD Comparison
ALMS vs NPFD Comparison
Compare ALMS & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- NPFD
- Stock Information
- Founded
- ALMS 2021
- NPFD 2021
- Country
- ALMS United States
- NPFD United States
- Employees
- ALMS N/A
- NPFD N/A
- Industry
- ALMS
- NPFD Trusts Except Educational Religious and Charitable
- Sector
- ALMS
- NPFD Finance
- Exchange
- ALMS NYSE
- NPFD Nasdaq
- Market Cap
- ALMS 402.6M
- NPFD N/A
- IPO Year
- ALMS 2024
- NPFD N/A
- Fundamental
- Price
- ALMS $4.28
- NPFD $18.34
- Analyst Decision
- ALMS Strong Buy
- NPFD
- Analyst Count
- ALMS 7
- NPFD 0
- Target Price
- ALMS $28.00
- NPFD N/A
- AVG Volume (30 Days)
- ALMS 678.0K
- NPFD 64.7K
- Earning Date
- ALMS 05-15-2025
- NPFD 01-01-0001
- Dividend Yield
- ALMS N/A
- NPFD 6.28%
- EPS Growth
- ALMS N/A
- NPFD N/A
- EPS
- ALMS N/A
- NPFD N/A
- Revenue
- ALMS N/A
- NPFD N/A
- Revenue This Year
- ALMS N/A
- NPFD N/A
- Revenue Next Year
- ALMS N/A
- NPFD N/A
- P/E Ratio
- ALMS N/A
- NPFD N/A
- Revenue Growth
- ALMS N/A
- NPFD N/A
- 52 Week Low
- ALMS $3.18
- NPFD $14.50
- 52 Week High
- ALMS $13.53
- NPFD $18.07
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- NPFD 51.80
- Support Level
- ALMS N/A
- NPFD $17.91
- Resistance Level
- ALMS N/A
- NPFD $18.47
- Average True Range (ATR)
- ALMS 0.00
- NPFD 0.37
- MACD
- ALMS 0.00
- NPFD 0.07
- Stochastic Oscillator
- ALMS 0.00
- NPFD 92.26
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.